HR-8385-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Frank Pallone (D-NJ)
What it does
This bill would update federal food labeling requirements, likely including changes to how nutritional information, ingredients, or other product details are displayed on food packaging. Because only the bill's title was provided and the full text was not included, the specific mechanical provisions — such as which labels are affected, what disclosures would be required, and which agency would enforce the rules — cannot be determined from the available text.
Who benefits
Consumers who rely on food labels to make purchasing decisions, including people managing chronic conditions such as diabetes, heart disease, or food allergies. Manufacturers who produce products that already meet updated standards would gain a competitive advantage. Public health researchers and advocacy organizations focused on diet-related disease prevention may benefit from improved data transparency.
Who is hurt
Food and beverage manufacturers that would need to redesign packaging to comply with new requirements, incurring printing and reformulation costs. Small and mid-sized food producers with fewer resources to absorb compliance costs may be disproportionately affected compared to large corporations. Retailers may face costs associated with updating inventory and shelf labeling systems.
Supporters argue
Supporters argue that existing food labeling rules have not kept pace with advances in nutritional science or changes in how Americans eat, and that clearer, more accurate labels would help consumers make better-informed choices. They contend that diet-related chronic diseases — including obesity, type 2 diabetes, and cardiovascular disease — impose hundreds of billions of dollars in annual healthcare costs, and that improved labeling is a low-cost, market-based tool to address these conditions without restricting consumer choice.
Opponents argue
Opponents argue that new labeling mandates impose real compliance costs on food manufacturers — particularly small businesses — without clear evidence that label changes meaningfully alter consumer behavior or health outcomes. They contend that the FDA already has broad authority to update labeling rules through existing regulation, making new legislation unnecessary, and that overly prescriptive federal standards could displace state-level labeling innovations that have served as effective policy laboratories.
Constitutional context
Congress regulates food labeling under the Commerce Clause (Art. I, §8, cl. 3), as food products move in interstate commerce. The FDA's authority to implement labeling rules may face heightened judicial scrutiny under Loper Bright v. Raimondo (2024), which eliminated automatic deference to agency interpretations of ambiguous statutes, meaning courts would independently assess whether any new FDA regulations fall within the bill's statutory authorization.
Checks and balances
Congress sets the labeling standards; the FDA (executive branch) would implement and enforce regulations; courts would review agency rules under the post-Loper Bright independent judgment standard, with no automatic deference to FDA interpretations.
Historical precedent
The Nutrition Labeling and Education Act of 1990 established the modern framework for FDA-regulated food labels, including the Nutrition Facts panel, and was subsequently updated by the Food Safety Modernization Act of 2011 and FDA rulemaking in 2016.